Dosing was initiated in a Phase 1 single and multiple ascending dose study of SCY-247, the Company's second-generation triterpenoid antifungal in development for the treatment of severe invasive ...

COVID-19 showed us that we urgently need more transparency in reporting adverse vaccine effects and that compensation for ...

Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the ...